Cytokines and Growth Factors Promote Airway Smooth Muscle Cell Proliferation

Chronic airway diseases, such as asthma or chronic obstructive pulmonary disease, are characterized by the presence in the airways of inflammation factors, growth factors and cytokines, which promote airway wall remodelling. The aim of this study was to investigate the effect of cytokines and growth factors on airway smooth muscle cell (ASMC) proliferation, phenotype and responsiveness. Incubation of serum starved human bronchial ASMCs with TNF-α, TGF, bFGF, and PDGF, but not IL-1β, increased methyl-[3H]thymidine incorporation and cell number, mediated by the PI3K and MAPK signalling pathways. Regarding rabbit tracheal ASMC proliferation, TNF-α, IL-1β, TGF, and PDGF increased methyl-[3H]thymidine incorporation in a PI3K- and MAPK-dependent manner. bFGF increased both methyl-[3H]thymidine incorporation and cell number. Moreover, incubation with TGF, bFGF and PDGF appears to drive human ASMCs towards a synthetic phenotype, as shown by the reduction of the percentage of cells expressing SM-α actin. In addition, the responsiveness of epithelium-denuded rabbit tracheal strips to carbachol was not significantly altered after 3-day treatment with bFGF. In conclusion, all the tested cytokines and growth factors increased ASMC proliferation to a different degree, depending on the specific cell type, with bronchial ASMCs being more prone to proliferation than tracheal ASMCs.

[1]  E. Paraskeva,et al.  The mitogenic effect of testosterone and 17β-estradiol on airway smooth muscle cells , 2011, Steroids.

[2]  K. Gourgoulianis,et al.  Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells , 2009, European Respiratory Journal.

[3]  D. Kim,et al.  TGF‐β effects on airway smooth muscle cell proliferation, VEGF release and signal transduction pathways , 2009, Respirology.

[4]  P. Pacher,et al.  Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation , 2008, Biochemical and biophysical research communications.

[5]  R. Panettieri,et al.  Mitogenic Effects of Cytokines on Smooth Muscle Are Critically Dependent on Protein Kinase A and Are Unmasked by Steroids and Cyclooxygenase Inhibitors , 2008, Molecular Pharmacology.

[6]  E. Paraskeva,et al.  Exposure of differentiated airway smooth muscle cells to serum stimulates both induction of hypoxia-inducible factor-1{alpha} and airway responsiveness to ACh. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[7]  J. Stankova,et al.  Fibroblast Growth Factor 2 and Transforming Growth Factor β1 Synergism in Human Bronchial Smooth Muscle Cell Proliferation , 2006 .

[8]  N. Khalil,et al.  TGF-β1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases , 2006, Respiratory research.

[9]  D. Knight,et al.  Structural changes in the airways in asthma: observations and consequences. , 2005, Clinical science.

[10]  K. Chung,et al.  Mitogen‐activated protein kinase signalling pathways in IL‐1β‐dependent rat airway smooth muscle proliferation , 2004, British journal of pharmacology.

[11]  T. Tran,et al.  Contribution of the p38MAPK signalling pathway to proliferation in human cultured airway smooth muscle cells is mitogen‐specific , 2004, British journal of pharmacology.

[12]  E. Paraskeva,et al.  Cobalt induces hypoxia-inducible factor-1alpha expression in airway smooth muscle cells by a reactive oxygen species- and PI3K-dependent mechanism. , 2004, American journal of respiratory cell and molecular biology.

[13]  R. Panettieri,et al.  Tumor Necrosis Factor α Modulates Airway Smooth Muscle Function via the Autocrine Action of Interferon β* , 2003, Journal of Biological Chemistry.

[14]  A. Halayko,et al.  Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma , 2003, Respiratory Physiology & Neurobiology.

[15]  I. Grzelewska-Rzymowska,et al.  [Airway remodeling in asthma]. , 2003, Pneumonologia i alergologia polska.

[16]  S. Shore,et al.  Effects of cytokines on contractile and dilator responses of airway smooth muscle , 2002, Clinical and experimental pharmacology & physiology.

[17]  G. Canonica,et al.  Human lung myofibroblasts as effectors of the inflammatory process: the common receptor γ  chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF‐α  , 2002 .

[18]  P. Montuschi,et al.  Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. , 2002, American journal of respiratory and critical care medicine.

[19]  H. S. Sharma,et al.  Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle , 2001, Respiratory research.

[20]  G. Canonica,et al.  Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha. , 2002, European journal of immunology.

[21]  D. Nelson,et al.  Linking cellular activation to cytoskeletal reorganization: Wiskott–Aldrich syndrome as a model , 2001, Current opinion in allergy and clinical immunology.

[22]  I. Hall,et al.  Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells. , 2001, American journal of respiratory cell and molecular biology.

[23]  A. Ammit,et al.  Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases. , 2001, Molecular pharmacology.

[24]  Y. Nakane,et al.  Negative Effect of Transforming Growth Factor-Beta-1 on Intestinal Anastomotic Tissue Regeneration , 2001, European Surgical Research.

[25]  R. Panettieri,et al.  Airway smooth muscle as an immunomodulatory cell: a new target for pharmacotherapy? , 2001, Current opinion in pharmacology.

[26]  H. Hoogsteden,et al.  Pro-inflammatory cytokines induce c-fos expression followed by IL-6 release in human airway smooth muscle cells. , 2001, Mediators of inflammation.

[27]  T. Lee,et al.  Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. , 2000, American journal of respiratory cell and molecular biology.

[28]  R. Panettieri,et al.  Activation of p55 tumor necrosis factor-alpha receptor-1 coupled to tumor necrosis factor receptor-associated factor 2 stimulates intercellular adhesion molecule-1 expression by modulating a thapsigargin-sensitive pathway in human tracheal smooth muscle cells. , 2000, Molecular pharmacology.

[29]  Chih‐Chung Lin,et al.  Tumour necrosis factor‐α‐ and interleukin‐1β‐stimulated cell proliferation through activation of mitogen‐activated protein kinase in canine tracheal smooth muscle cells , 2000 .

[30]  K. Chung,et al.  Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation? , 2000, The European respiratory journal.

[31]  H. Hoogsteden,et al.  Tumor necrosis factor-alpha enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells. , 2000, American journal of respiratory cell and molecular biology.

[32]  H. Hoogsteden,et al.  Tumor Necrosis Factor-a Enhances mRNA Expression and Secretion of Interleukin-6 in Cultured Human Airway Smooth Muscle Cells , 2000 .

[33]  J. Benovic,et al.  MAPK superfamily activation in human airway smooth muscle: mitogenesis requires prolonged p42/p44 activation. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[34]  E. Chilvers,et al.  Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[35]  Q. Hamid,et al.  Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. , 1999, American journal of respiratory and critical care medicine.

[36]  R. Vlahos,et al.  Interleukin‐1α and tumour necrosis factor‐α modulate airway smooth muscle DNA synthesis by induction of cyclo‐oxygenase‐2: inhibition by dexamethasone and fluticasone propionate , 1999 .

[37]  Alexander Levitzki,et al.  Activation of the Ras/Mitogen-Activated Protein Kinase Pathway by Kinase-Defective Epidermal Growth Factor Receptors Results in Cell Survival but Not Proliferation , 1998, Molecular and Cellular Biology.

[38]  C. Page,et al.  Inhibition of serum and transforming growth factor beta (TGF‐β1)‐induced DNA synthesis in confluent airway smooth muscle by heparin , 1998, British journal of pharmacology.

[39]  W. Kuo,et al.  MEK1 is required for PDGF-induced ERK activation and DNA synthesis in tracheal myocytes. , 1997, The American journal of physiology.

[40]  C. Bronner,et al.  Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. , 1996, American journal of respiratory cell and molecular biology.

[41]  C. Feighery,et al.  Leukocyte function‐associated antigen 1 (LFA‐1) and CD44 are signalling molecules for cytoskeleton‐dependent morphological changes in activated T cells , 1995, Journal of leukocyte biology.

[42]  C. Bronner,et al.  Ca2+ increase and Ca2+‐influx in human tracheal smooth muscle cells: role of Ca2+ pools controlled by sarco‐endoplasmic reticulum Ca2+‐ATPase 2 isoform , 1995, British journal of pharmacology.

[43]  M. Berridge,et al.  Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. , 1993, Archives of biochemistry and biophysics.

[44]  J. G. Cory,et al.  Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. , 1991, Cancer communications.

[45]  R. Ross,et al.  TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. , 1990, Cell.

[46]  M. Majesky,et al.  Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta , 1990, The Journal of cell biology.

[47]  R. Majack,et al.  Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. , 1989, The Journal of biological chemistry.

[48]  R. Majack.  Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures , 1987, The Journal of cell biology.